BuzzSparks.org

Biolex Therapeutics


Healthcare Biotechnology

Biolex is a clinical-stage biopharmaceutical company that uses their patented LEX SystemSM to develop hard-to-make therapeutic proteins and monoclonal antibodies that have been optimized to enhance their efficacy and potency. The LEX System is a...

Founded in 1997
Employees: 105
Homepage:
Total money raised: $156.4M

Headquarters

27312 158 Credle Street

Pittsboro
USA NC

Phone: 919.542.9901

Updated on Sep 16, 2013
Biolex Therapeutics at CrunchBase
Tags:   biotech   clinical   clinical-stage   hepatitis   lemna   locteron   stage   therapeutic

Kevin Bitterman Director
Chau Q. Khuong Board of Director
Kyle Chenet Director
Past
Jan Turek President and CEO

June, 2012

deadpooled

December, 2011

Biolex Therapeutics raised $2.4M in debt_round round

SEC    sec.gov

October, 2010

Biolex Therapeutics raised $20M in a Series D round

Biolex Gets $20M From Insiders, Sees Strong Data From Hepatitis C Drug    fis.dowjones.com

October, 2008

Biolex Therapeutics raised $60M in a Series D round from Dow Venture Capital, Johnson & Johnson Development Corporation, Clarus Ventures, Quaker BioVentures, Bioventures Investors, J.P. Morgan Securities Inc., InterSouth Partners, OrbiMed Advisors, Dogwood Equity, Investor Growth Capital, and Mitsui Ventures

Biolex Therapeutics Completes $60 Million Series D Financing to Accelerate Development of Locteron® in Hepatitis C    mitsuiventures.com

May, 2007

Biolex Therapeutics raised $30M in a Series C round from Investor Growth Capital, J.P. Morgan Securities Inc., Easton Capital, Quaker BioVentures, Polaris Venture Partners, InterSouth Partners, Mitsui Ventures, Johnson & Johnson Development Corporation, and Dow Venture Capital

BIOLEX THERAPEUTICS RAISES $30 MILLION TO ADVANCE ITS HEPATITIS C DRUG CANDIDATE AND OTHER PIPELINE PROGRAMS    biolex.com

September, 2005

Biolex Therapeutics raised $36M in a Series B round from Polaris Venture Partners, InterSouth Partners, Quaker BioVentures, Johnson & Johnson Development Corporation, Mitsui Ventures, and Kitty Hawk Capital

BIOLEX THERAPEUTICS RAISES $36 MILLION IN VENTURE FINANCING    biolex.com

January, 2005

Biolex Therapeutics raised $8M in unattributed round from Johnson & Johnson Development Corporation

1997

Biolex Therapeutics was founded in 1997